Evidence map›Paper›PMID 41140222›Full record

ReviewMini reviews in medicinal chemistry2026

Therapeutic and Pharmacological Flexibility of Cinnamoyl Compounds: Targeting Multiple Signaling Pathways.

Navin Kumar Tailor, Sonima Prasad, Sandeep Kumar Singh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mini reviews in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Navin Kumar TailorUniversity Institute of Pharma Sciences, Chandigarh University, Ghaurn Mohali, 140413, India.
Sonima PrasadUniversity Institute of Pharma Sciences, Chandigarh University, Ghaurn Mohali, 140413, India.
Sandeep Kumar SinghDepartment of Medical Biotechnology, All India Institute of Medical Sciences (AIIMS), Nagpur, MH, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extensive array of Natural Products (NPs), ranging from plants to microbes, is wellknown for their varied chemical characteristics and significant biological activity. Historically significant in drug discovery, natural products provide distinctive stereochemistry and complexity generated by diverse biosynthetic pathways. Structural alterations improve effectiveness and diminish adverse effects, driven by advancements in screening, chemistry, and bioinformatics. Natural products have been approved as drug candidates despite the laborious process involved in their isolation and elucidation, demonstrating their relevance. Cinnamaldehyde (CA), derived from Cinnamomum tree bark, exhibits antibacterial, anti-inflammatory, anticancer, antioxidant, neuroprotective, antifungal, and anti-diabetic properties by affecting cellular processes and signaling pathways like PI3K/AKT/mTOR, TGF-β/Smad, NF-κB, TLR4/MyD88/NF-κB, MAPKs, JAK/STAT, and Nrf2/HO-1. Small molecular entities, along with the presence of α,β-unsaturated carbonyl functionality, offer intriguing possibilities within the research framework of synthetic chemistry. Synthetic analogues of CA have been produced; nonetheless, their biological actions remain largely unexamined. The review highlights the pharmacological significance of cinnamoyl functionality, indicating its potential for creating multi-targeted drugs through unexamined structural changes. This review adopts a comprehensive study design, featuring an extensive search of databases like PubMed, Science Direct and Scopus using keywords such as "cinnamoyl compounds," "synthetic derivatives," "therapeutic flexibility," and "pharmacological pathways." Studies were selected based on their relevance to the pharmacological activities of cinnamoyl compounds' synthetic derivatives and their effects on multiple signaling pathways in therapeutic contexts, including experimental data. This article aims to provide theoretical support for the promising development of cinnamoyl compounds as potential candidates for new discoveries and therapeutic advancements.

Indexed as

AcroleinBiological ProductsSignal TransductionAnimalsAntioxidantsHumansAcroleinAntioxidantsBiological ProductscinnamaldehydeanticancerCinnamaldehydeMAPKsNF-κBNrf2/HO-1 measles virusPI3K/AKT/mTOR

Identifiers

PMID41140222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.